| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PAHC over the last quarter tilts toward buying: insiders added a net 10,000 shares worth roughly $318K.
PAHC sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 51.5K | $1.87M | - | |
| Dir | 41.5K | $1.51M | - | |
| COO | 34.5K | $1.25M | - | |
| Other | 14.5K | $528.0K | - | |
| CEO | 3.5K | $126.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2018 | Warras Dean J | Pres Animal Health &Nutr N.a. | Sale+OE | 10,000 | $35.62 | $356,200.00 | -100% | |
| Sep 15, 2017 | Warras Dean J | Pres Animal Health &Nutr N.a. | Sale+OE | 10,000 | $35.70 | $357,008.00 | -64.1% | |
| Sep 14, 2017 | Miller Larry Lee | Chief Operating Officer | Sale+OE | 21,439 | $36.43 | $781,000.18 | -100% | |
| Sep 14, 2017 | Johnson Richard G | Chief Financial Officer | Sale+OE | 55,529 | $36.30 | $2,015,472.67 | -100% | |
| Sep 12, 2017 | Johnson Richard G | Chief Financial Officer | Sale+OE | 47,264 | $36.32 | $1,716,455.59 | -100% | |
| Sep 12, 2017 | Miller Larry Lee | Chief Operating Officer | Sale+OE | 46,102 | $36.33 | $1,674,693.10 | -100% | |
| Sep 11, 2017 | Carlson Gerald K | Director | Sale+OE | 5,400 | $36.27 | $195,858.00 | -100% | |
| Sep 7, 2017 | Miller Larry Lee | Chief Operating Officer | Sale+OE | 32,459 | $35.59 | $1,155,110.56 | -100% | |
| Sep 7, 2017 | Johnson Richard G | Chief Financial Officer | Sale+OE | 29,807 | $35.66 | $1,062,807.57 | -100% | |
| Aug 21, 2017 | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sale+OE | 4,976 | $40.01 | $199,097.76 | -100% |